Coldstream Capital Management Inc Akero Therapeutics, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 253 shares of AKRO stock, worth $11,364. This represents 0.0% of its overall portfolio holdings.
Number of Shares
253Holding current value
$11,364% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AKRO
# of Institutions
249Shares Held
80.1MCall Options Held
228KPut Options Held
943K-
Rtw Investments, LP New York, NY7.42MShares$333 Million4.92% of portfolio
-
Janus Henderson Group PLC London, X07.07MShares$318 Million0.16% of portfolio
-
Wellington Management Group LLP Boston, MA5.94MShares$267 Million0.05% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$251 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$235 Million7.15% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.09B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...